黄卓团队发现卡维地洛抑制KCNT1基因突变引起的新生儿恶性癫痫, 为治疗难治性癫痫提供新希望
北京大学药学院天然药物及仿生药物全国重点实验室
The research team of Prof. Zhuo Huang found that Carvedilol inhibits neonatal malignant epilepsy caused by KCNT1 mutation, providing new hope for the treatment of refractory epilepsy
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
中国药学(英文版)
.
2024, (11): 1092
-1094
.
>
>